Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BrightSpring Health Services (BTSG) EBITDA Margin (2023 - 2025)

BrightSpring Health Services' EBITDA Margin history spans 3 years, with the latest figure at 3.04% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 102.0% year-over-year to 3.04%; the TTM value through Dec 2025 reached 2.29%, up 122.0%, while the annual FY2025 figure was 2.29%, 122.0% up from the prior year.
  • EBITDA Margin reached 3.04% in Q4 2025 per BTSG's latest filing, up from 2.63% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 3.67% in Q2 2023 to a low of 9.99% in Q4 2023.
  • Average EBITDA Margin over 3 years is 0.58%, with a median of 1.67% recorded in 2024.
  • The largest YoY upside for EBITDA Margin was 1201bps in 2024 against a maximum downside of -321bps in 2024.
  • A 3-year view of EBITDA Margin shows it stood at 9.99% in 2023, then skyrocketed by 120bps to 2.02% in 2024, then surged by 51bps to 3.04% in 2025.
  • Per Business Quant, the three most recent readings for BTSG's EBITDA Margin are 3.04% (Q4 2025), 2.63% (Q3 2025), and 1.54% (Q2 2025).